BridgeMD
New treatment option for Stroke
Official title Brain-computer Interface With Plantar Pneumoorthoses for Post-stroke Rehabilitation
ClinicalTrials.gov ID: NCT07081308
What this study is testing
- What it's testing
- STUDY PURPOSE The investigators are testing a new rehabilitation system that helps stroke patients recover their ability to walk and think more clearly. This system, called brain-computer interface with plantar pneumorthoses, uses brain signals to control a special device that provides gentle pressure to the feet, similar to what you feel when walking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18-80 years
- Primary or recurrent supratentorial ischemic stroke
- Stroke onset 7 days to 24 months
- Moderate to mild post-stroke lower limb motor impairments
- Clinical stability
You likely can't join if
- Severe cognitive impairments preventing instruction compliance
- Sensory or severe motor aphasia
- Severe visual impairments
- Lower limb contractures
- Inability to maintain sitting position
See the full eligibility criteria
- Age 18-80 years
- Primary or recurrent supratentorial ischemic stroke
- Stroke onset 7 days to 24 months
- Moderate to mild post-stroke lower limb motor impairments
- Clinical stability
- Voluntary participation and signing of informed consent
- Severe cognitive impairments preventing instruction compliance
- Sensory or severe motor aphasia
- Severe visual impairments
- Lower limb contractures
- Inability to maintain sitting position
The study team makes the final eligibility decision.
Where it's taking place
- Moscow, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Moscow, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.